These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8544183)

  • 1. Novel inhibitors for multidrug resistance: 1,3,5-triazacycloheptanes.
    Sawanishi H; Wakusawa S; Murakami R; Muramatsu H; Suzuki H; Takashima A; Aizawa T; Miyamoto K
    J Med Chem; 1995 Dec; 38(26):5066-70. PubMed ID: 8544183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro anti-multidrug resistance activities of acyclic and cyclic disulfonamides in murine leukemia cells.
    Wakusawa S; Sawanishi H; Hayashi H
    Anticancer Res; 1998; 18(4C):2961-5. PubMed ID: 9713492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumour effects and pharmacokinetics of combination of vinblastine with a staurosporine derivative, NA-382, in P388/ADR-bearing mice.
    Miyamoto K; Takeda K; Koga K; Ohshima T; Wakusawa S
    J Pharm Pharmacol; 1995 Jun; 47(6):524-9. PubMed ID: 7674138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
    Nakashima E; Matsushita R; Negishi H; Nomura M; Harada S; Yamamoto H; Miyamoto K; Ichimura F
    J Pharm Sci; 1995 Oct; 84(10):1205-9. PubMed ID: 8801335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circumvention of multidrug resistance in P388 murine leukemia cells by a novel inhibitor of cyclic AMP-dependent protein kinase, H-87.
    Miyamoto K; Wakusawa S; Nakamura S; Koshiura R; Otsuka K; Naito K; Hagiwara M; Hidaka H
    Cancer Lett; 1990 May; 51(1):37-42. PubMed ID: 2337896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
    Miyamoto K; Inoko K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M
    Cancer Res; 1993 Apr; 53(7):1555-9. PubMed ID: 8095855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
    Wakusawa S; Nakamura S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
    Mol Pharmacol; 1992 Jun; 41(6):1034-8. PubMed ID: 1614407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.
    Wang L; Kitaichi K; Hui CS; Takagi K; Takagi K; Sakai M; Yokogawa K; Miyamoto KI; Hasegawa T
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):587-93. PubMed ID: 10901387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells.
    Miyamoto KI; Koga-Takeda K; Koga K; Ohshima T; Nomura M
    J Pharm Pharmacol; 1996 May; 48(5):522-5. PubMed ID: 8799879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of diamines, dicarboxamides, and disulfonamides on vinblastine accumulation in P388/ADR cells.
    Sawanishi H; Wakusawa S; Murakami R; Miyamoto K; Tanaka K; Yoshifuji S
    Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1459-62. PubMed ID: 7923469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
    Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
    Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells.
    Wang FP; Wang L; Yang JS; Nomura M; Miyamoto K
    Biol Pharm Bull; 2005 Oct; 28(10):1979-82. PubMed ID: 16204959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids.
    Hasegawa H; Sung JH; Matsumiya S; Uchiyama M; Inouye Y; Kasai R; Yamasaki K
    Planta Med; 1995 Oct; 61(5):409-13. PubMed ID: 7480200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
    Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells.
    Parekh H; Chitnis M
    Sel Cancer Ther; 1990; 6(2):93-102. PubMed ID: 2367755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of staurosporine derivatives on protein kinase activity and vinblastine accumulation in mouse leukaemia P388/ADR cells.
    Miyamoto K; Inoko K; Ikeda K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M
    J Pharm Pharmacol; 1993 Jan; 45(1):43-7. PubMed ID: 8094445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells.
    Nakamura S; Wakusawa S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
    J Pharm Pharmacol; 1993 Apr; 45(4):268-73. PubMed ID: 8098366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.
    Dantzig AH; Shepard RL; Cao J; Law KL; Ehlhardt WJ; Baughman TM; Bumol TF; Starling JJ
    Cancer Res; 1996 Sep; 56(18):4171-9. PubMed ID: 8797588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine and phenylalanine restriction sensitizes adriamycin-resistant P388 leukemia cells to adriamycin.
    Elstad CA; Thrall BD; Raha G; Meadows GG
    Nutr Cancer; 1996; 25(1):47-60. PubMed ID: 8837861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.